Covestor LTD Charles River Laboratories International, Inc. Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Covestor LTD holds 327 shares of CRL stock, worth $60,756. This represents 0.04% of its overall portfolio holdings.

Number of Shares

327

Previous 232 40.95%

Holding current value

$60,756

Previous $48,000 35.42%

% of portfolio

0.04%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$187.96 - $245.29 $17,856 - $23,302	95 Added 40.95%	327 $65,000
Q2 2024 Aug 09, 2024	BUY	$206.39 - $268.73 $11,351 - $14,780	55 Added 31.07%	232 $48,000
Q1 2024 May 10, 2024	SELL	$203.52 - $273.43 $7,123 - $9,570	-35 Reduced 16.51%	177 $48,000
Q4 2023 Feb 09, 2024	BUY	$164.52 - $238.84 $822 - $1,194	5 Added 2.42%	212 $50,000
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $2,333 - $2,611	-12 Reduced 5.48%	207 $41,000
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $29,026 - $33,219	158 Added 259.02%	219 $46,000
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $5,181 - $7,017	-27 Reduced 30.68%	61 $12,000
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $1,379 - $1,750	7 Added 8.64%	88 $19,000
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $7,480 - $10,272	41 Added 102.5%	81 $16,000
Q2 2022 Aug 10, 2022	SELL	$204.13 - $302.4 $27,353 - $40,521	-134 Reduced 77.01%	40 $9,000
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $22,229 - $31,503	87 Added 100.0%	174 $49,000
Q4 2021 Feb 10, 2022	BUY	$351.38 - $448.68 $30,570 - $39,035	87 New	87 $33,000

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account